This inventor holds 5 USPTO granted patents. Top assignees: Egis Gyogyszergyar, Biogal Gyogyszergyar, Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1988-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1988-1989
Title: Maria Kuhar Nee Kurthy: Innovator in Pharmaceutical Chemistry
Introduction
Maria Kuhar Nee Kurthy is a distinguished inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. Her work focuses on developing novel compounds that have potential therapeutic applications.
Latest Patents
Among her latest patents, Maria has developed 1-(hydroxystyrl)-5H-2,3-benzodiazepine derivatives. This invention relates to new derivatives of the general formula (I) and includes a process for their preparation, as well as pharmaceutical compositions containing these compounds. Additionally, she has worked on novel 3(2H)-pyridazinone derivatives, which also have pharmaceutical applications. These compounds are characterized by their unique structural features, which include various substituents that enhance their efficacy.
Career Highlights
Maria has had a fruitful career, working with notable companies such as Egis Gyógyszergyár and Richter Gedeon Vegyészeti Gyár Rt. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Throughout her career, Maria has collaborated with esteemed colleagues, including Istvan Elekes and Gyorgy Rabloczky. These partnerships have fostered innovation and have been instrumental in advancing her research projects.
Conclusion
Maria Kuhar Nee Kurthy is a prominent figure in pharmaceutical innovation, with a strong portfolio of patents that reflect her expertise and dedication to improving healthcare through chemistry. Her contributions continue to influence the field and inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile